Results 1 - 3 of 3
1
[PROJECT] SILVER - Small-molecule Inhibitor Leads Versus emerging and neglected RNA viruses
ID: 260644
Start date: 2010-10-01, End date: 2015-03-31
RNA virus infections kill millions of humans annually, largely due to the lack of suitable vaccines and drugs to control them. This problem is addressed in this FP7 call and in response a consortium of Europe’s and Asia’s leading molecular virologists, structural biologists, ...
Programme: FP7-HEALTH
Record Number: 96747
Last updated on: 2017-05-26
[PROJECT] ORCHID - Open Collaborative Model for Tuberculosis Lead Optimisation
ID: 261378
Start date: 2011-01-01, End date: 2015-06-30
"Early stage Drug Discovery efforts over the last 5 years have resulted in the identification of a number of promising lead compounds in the fight against TB. These leads need to be further progressed and optimised into candidates for pre-clinical development through the Drug...
Programme: FP7-HEALTH
Record Number: 96802
Last updated on: 2017-05-26
[PROJECT] LEISHDRUG - Targeting the Leishmania kinome for the development of novel anti-parasitic strategies
ID: 223414
Start date: 2008-10-01, End date: 2012-03-31
Visceral leishmaniasis is caused by the protozoan parasites Leishmania donovani and Leishmania infantum and is a potentially fatal disease in endemic areas around the world. During the infectious cycle, Leishmania alternate between the insect promastigote stage and the verteb...
Programme: FP7-HEALTH
Record Number: 88852
Last updated on: 2017-05-29
List retrieved on: 2017-08-02
